Actively Recruiting
Comparison of Tumor Efficacy Safety in Laparoscopic Resection of Gastrointestinal Stromal Tumors Between Favorable and Unfavorable Site
Led by Fujian Medical University · Updated on 2025-04-08
250
Participants Needed
1
Research Sites
442 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Participants with gastrointestinal stromal tumors(GIST) were divided into favorable and unfavorable sites according to the anatomical site of the tumor, and this study aims to validate the overall postoperative morbidity and mortality rates between favorable site receiving laparoscopic resection of GIST and that of unfavorable site under the currently standard surgical therapy.
CONDITIONS
Official Title
Comparison of Tumor Efficacy Safety in Laparoscopic Resection of Gastrointestinal Stromal Tumors Between Favorable and Unfavorable Site
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 75 years old
- Primary gastric lesion confirmed pathologically as GIST by endoscopic biopsy
- Preoperative suspicion of GIST by endoscopy, ultrasound endoscopy, CT, or MRI with postoperative confirmation
- Written informed consent provided
- Expected complete tumor removal (R0 resection) by laparoscopy
- Eastern Cooperative Oncology Group performance status of 0 or 1
- American Society of Anesthesiology class I to III
- Maximum tumor diameter of 10 cm or less
You will not qualify if you...
- Pregnant or lactating women
- Severe mental disorder
- Previous upper abdominal surgery except laparoscopic cholecystectomy
- Previous gastric surgery including endoscopic submucosal dissection or mucosal resection for gastric cancer
- Refusal of laparoscopic resection
- Other malignant disease within the past five years
- Unstable angina or myocardial infarction within the past six months
- Cerebrovascular accident within the past six months
- Continuous corticosteroid use within one month
- Need for simultaneous surgery for another disease
- Emergency surgery due to complications from gastric cancer such as bleeding, obstruction, or perforation
- Forced expiratory volume in 1 second (FEV1) less than 50% of predicted
- Tumor diameter greater than 10 cm
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fujian Medical University Union Hospital
Fuzhou, Fujian, China, 350001
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here